SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-24-000115
Filing Date
2024-08-13
Accepted
2024-08-13 16:15:14
Documents
83
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 10-Q cdtx-20240630.htm   iXBRL 10-Q 1598923
2 2020 INDUCEMENT INCENTIVE PLAN, AS AMENDED exhibit1032024-06.htm EX-10.3 191201
3 LICENSE AND TECHNOLOGY AGREEMENT exhibit1042024-06.htm EX-10.4 460850
4 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3112024-06.htm EX-31.1 10381
5 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3122024-06.htm EX-31.2 10391
6 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3212024-06.htm EX-32.1 7856
7 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3222024-06.htm EX-32.2 7936
13 GRAPHIC cdtx-20240630_g1.jpg GRAPHIC 436119
14 GRAPHIC cdtx-20240630_g10.jpg GRAPHIC 726427
15 GRAPHIC cdtx-20240630_g11.jpg GRAPHIC 525805
16 GRAPHIC cdtx-20240630_g2.jpg GRAPHIC 255647
17 GRAPHIC cdtx-20240630_g3.jpg GRAPHIC 457400
18 GRAPHIC cdtx-20240630_g4.jpg GRAPHIC 236043
19 GRAPHIC cdtx-20240630_g5.jpg GRAPHIC 571565
20 GRAPHIC cdtx-20240630_g6.jpg GRAPHIC 598873
21 GRAPHIC cdtx-20240630_g7.jpg GRAPHIC 353152
22 GRAPHIC cdtx-20240630_g8.jpg GRAPHIC 574435
23 GRAPHIC cdtx-20240630_g9.jpg GRAPHIC 678635
24 GRAPHIC image_0a.jpg GRAPHIC 110009
  Complete submission text file 0001610618-24-000115.txt   21767158

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20240630.xsd EX-101.SCH 52153
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20240630_cal.xml EX-101.CAL 86405
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20240630_def.xml EX-101.DEF 350188
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20240630_lab.xml EX-101.LAB 624416
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20240630_pre.xml EX-101.PRE 503986
86 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20240630_htm.xml XML 1115003
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 241201657
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)